id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1445164,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,TAX,"Possible changes in the tax code that affect the pharmaceutical industry, including the R&D tax credit and the Orphan Drug tax credit.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00
1445165,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,HCR,"Implementation of, and possible change/repeal to provisions related to the Patient Protection and Affordable Care Act (PL 111-178) and the Reconciliation Act (PL 111-152), including implementation of biosimilars provisions and the Independent Payment Advisory Board.  General issues related to reimbursement for pharmaceuticals, including drug pricing, orphan drugs, reimbursement for pharmaceuticals under Medicare Parts B and D, and 340B clinics.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00
1445166,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,MMM,"Budget and deficit reduction proposals that may affect the Medicare and Medicaid programs, including issues related to End Stage Renal Disease, and Sustainable Growth Rate and Average Sales Price calculations.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00
1445167,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,PHA,"Adequate funding for programs of the Food and Drug Administration, including implementation of the Prescription Drug User Fee Act (FY 2014 appropriations for the FDA, H.R. 2410/S. 1244/H.J. Res. 59).  Assess potential impact of sequestration on public health/food and drug programs (FY 2014 appropriations for HHS, S. 1284).","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00